- Merck PCSK9 Pill Results Point to Extremely Low Cholesterol Future The New York Times
- Experimental daily pill may lower cholesterol in patients who don’t see enough benefit with statins alone, study finds CNN
- Merck’s pill to reduce cholesterol on top of statins matches results from injectables statnews.com
- Oral PCSK9 Inhibitor Enlicitide Matches Injectables in Lowering LDL Cholesterol AJMC
- Merck’s enlicitide decanoate significantly reduced ldl-c in phase 3 coralreef lipids trial MarketScreener
